6.79

0.59% 0.04

Cumberland Pharmaceuticals Inc (CPIX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cumberland Pharmaceuticals Inc stock is traded at $6.79, with a volume of 14,026. It is up +0.59% in the last 24 hours and down -12.61% over the past month. Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Previous Close:

$6.75

Open:

$6.75

24h Volume:

14,026

Relative Volume:

0.14

Market Cap:

$101.74M

Revenue:

$41.94M

Net Income/Loss:

$-7.40M

P/E Ratio:

-13.76

EPS:

-0.4935

Net Cash Flow:

$1.29M

1W Performance:

-19.74%

1M Performance:

-12.61%

6M Performance:

+85.01%

1Y Performance:

+85.52%

1-Day Range:

$6.65

$6.90

1-Week Range:

$6.28

$8.50

52-Week Range:

$1.85

$9.2799

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name

Cumberland Pharmaceuticals Inc

Sector

Healthcare (1074)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

615-255-0068

Address

1600 WEST END AVENUE, NASHVILLE,, TN

Employee

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

CPIX's Discussions on Twitter

Compare CPIX vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPIX Cumberland Pharmaceuticals Inc	6.79	112.37M	41.94M	-7.40M	1.29M	-0.4935
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-12-12	Reiterated	UBS	Neutral
Feb-01-11	Reiterated	UBS	Neutral
Dec-16-10	Downgrade	UBS	Buy → Neutral
Aug-17-10	Downgrade	Jefferies	Buy → Hold
Aug-17-10	Reiterated	Morgan Joseph	Buy
Aug-17-10	Reiterated	UBS	Buy
May-14-10	Reiterated	Morgan Joseph	Buy

View All

Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News

Aug 20, 2026

Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Aug 20, 2026

Aug 16, 2026

Enterprise value to revenue forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView

Aug 16, 2026

Price to sales forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView

Aug 16, 2026

Price to book forward of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView

Aug 16, 2026

Cumberland Pharmaceuticals (CPIX) Slips 1.4% to $7.79 as Shares Remain RangeboundHigh Conviction Picks - dars.gov.et

Aug 16, 2026

Aug 14, 2026

Cumberland Pharmaceuticals Stock Price Forecast. Should You Buy CPIX? - StockInvest.us

Aug 14, 2026